- Merck & Co. (MA)
- …develop both short- and long-term account plans in conjunction with a wide array of stakeholders, proactively working with the account team and supervisor (known as ... the Customer Team Leader) to effectively execute the account plan. Share learnings and best-practices from one customer to help other customers meet their needs.Influence beyond their specific geography or product area demonstrate advanced ability to ask… more
- Legend Biotech USA, Inc. (Piscataway, NJ)
- …New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor ... T-cell and natural killer (NK) cell-based immunotherapy.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel… more
- Legend Biotech USA, Inc. (Iowa City, IA)
- …New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor ... T-cell and natural killer (NK) cell-based immunotherapy.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor ... T-cell and natural killer (NK) cell-based immunotherapy.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel… more
- Merck & Co. (South San Francisco, CA)
- …exposure to high-throughput lab operations, automation, and compound array purification#EligibleforERP-Current Employees apply HERE Current Contingent Workers apply ... HERE US and Puerto Rico Residents Only:Our company is committed to inclusion, ensuring that candidates can engage in a hiring process that exhibits their true capabilities. Please click here if you need an accommodation during the application or hiring… more
- Legend Biotech USA, Inc. (Boston, MA)
- …New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor ... T-cell and natural killer (NK) cell-based immunotherapy.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …initiatives to support changing payroll tax regulations and supporting a complex array of tax and deduction calculations for existing locations and future growth ... and expansion, while managing a team of two in a fast-paced, rapidly growing environment. This role will be responsible for managing multiple vendor relationships, internal and external auditors and payroll and tax providers. The individual will also… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor ... T-cell and natural killer (NK) cell-based immunotherapy.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor ... T-cell and natural killer (NK) cell-based immunotherapy.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel… more
- Legend Biotech USA, Inc. (Charlotte, NC)
- …New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor ... T-cell and natural killer (NK) cell-based immunotherapy.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor ... T-cell and natural killer (NK) cell-based immunotherapy.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel… more
- Merck & Co. (Rahway, NJ)
- …define IT and infrastructure deliverables, timelines and estimates for a wide array of technologies and deliver value-added IT services and infrastructure solutions ... while ensuring strategies to adapt to technological advancements.Collaborate closely with stakeholders and translate business needs into actionable requirements while acting as a conduit to development and infrastructure engineers.Contributes to the… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor ... T-cell and natural killer (NK) cell-based immunotherapy.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor ... T-cell and natural killer (NK) cell-based immunotherapy.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor ... T-cell and natural killer (NK) cell-based immunotherapy.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor ... T-cell and natural killer (NK) cell-based immunotherapy.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor ... T-cell and natural killer (NK) cell-based immunotherapy.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor ... T-cell and natural killer (NK) cell-based immunotherapy.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor ... T-cell and natural killer (NK) cell-based immunotherapy.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor ... T-cell and natural killer (NK) cell-based immunotherapy.Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel… more
Related Job Searches:
Field Programmable Gate Array,
HV Battery Mechanical Array,
High Voltage Battery Array,
Phased Array,
Phased Array Antenna,
Phased Array Level,
Signal Processing Array Engineer,
Solid State Phased Array,
Spacecraft Solar Array Engineer,
Sr Electrical Engineer Array